Wan sɔlv fɔ kɔlaytis? Mek wi lan bɔt Vedolizumab!

Yu de sɔfa wit Inflammatory Bowel Disease ( IBD ), we na wan sik we di layn na di intestines kin inflamed ɛn sɔri ? Na di wan dɛm nɔmɔ wae dɔn gɛt dis pen no aw e kin tranga fɔ liv wit sik lɛk Kron sik ɔr Ulcerative Colitis . Bɔt nɔ fred, wit di advans we di mɛdikal sayɛns de go bifo, nyu ɛn fayn tritmɛnt dɛn dɔn kam fɔ kɔntrol dɛn sik ya. Tide, wi go tɔk bɔt wan pan dɛn spɛshal mɛrɛsin dɛn de, we na Vedolizumab .

Wetin na dis mɛrɛsin we dɛn kɔl Vedolizumab? I min se...

Fɔ tɔk am simpul wan, Vedolizumab na wan mɛrɛsin we dɛn kin yuz fɔ trit sɔm inflammatory bowel diseases , mɔ di Crohn’s disease ɛn ulcerative colitis. If yu gɛt wan pan dɛn sik ya, yu go dɔn yɛri bɔt dis mɛrɛsin, ɔ yu dɔktɔ go dɔn tɛl yu fɔ du am.

Wetin dis drɔg kin rili du? Tink bɔt am, di men wok we i de du na fɔ ridyus di inflamɛns we nɔ nid fɔ de na yu dijestiv sistɛm, dat na, na di intestinal . Sɔm sɛl dɛn na wi bɔdi in imyun sistɛm kin ɛp fɔ mek dis inflamɛns. Vedolizumab de stɔp dɛn sɛl dɛn de fɔ go insay ɛn pwɛl di intestinal tisu dɛn. Lɛk pɔsin we de kia fɔ di get, dis drɔg de blok di we fɔ mek dɛn sɛl dɛn de we de mek di bɔdi wam, go insay di insay. Dɔn de diskɔmfɔt we yu kin fil, lɛk bɛlɛ pen , dayarɛa, ɛn blɔd, kin ridyus bad bad wan ɛn yu kin gɛt fridɔm.

Wetin na de tin wae yu nid fɔ tɛl yu dɔktɔ bifo yu yuse dis mɛrɛsin?

Bifo yu bigin fɔ trit yu wit Vedolizumab, i impɔtant fɔ tɛl yu mɛdikal tim, inklud yu dɔktɔ ɛn nɔs, bɔt dɛn tin ya. Dis infɔmeshɔn go ɛp dɛn fɔ disayd if dis mɛrɛsin fayn fɔ yu, aw dɛn go gi am, ɛn wetin yu nid fɔ no bɔt. Nɔ ayd dis infɔmeshɔn, bikɔs i kin ambɔg yu.

• Yu gɛt ɛni alɛji?Yu kin gɛt alɛji fɔ Vedolizumab insɛf, ɔ ɔda mɛrɛsin, it, day, ɔ tin dɛn we de mek yu nɔ pwɛl. So mek yu no klia wan bɔt dat. If yu bin dɔn gɛt ɛni alɛji fɔ ɛni mɛrɛsin bifo, tɛl wi bɔt am bak.
• Yu gɛt ɛni infɛkshɔn naw? Fɔ ɛgzampul, if yu gɛt siriɔs infekshɔn lɛk Tuberculosis (TB) , ɔ ɛni ɔda baktri, fɛns, ɔ vayral infɛkshɔn, yu fɔ tɛl yu dɔktɔ. If yu gɛt sɔm sayn dɛn lɛk fiva, kɔf, ɔ blɔd, tɛl yu dɔktɔ. Dis na bikɔs dis mɛrɛsin kin afɛkt di imyun sistɛm, we kin mek wan infɛkshɔn we dɔn de, wɔs.
• Yu gɛt ɛni sik na yu liva? Di liva na wan ɔgan we rili impɔtant na wi bɔdi. di liva de εp fכ mεtabolayz εn kכl mεdikeshכn dεm na di bכdi. So, if prɔblɛm de wit di liva, i kin afɛkt di tritmɛnt.
• Yu dɔn gɛt ɛni vaysin i nɔ tu te yet? Ɔ yu de plan fɔ gɛt ɛni wan tumara bambay? Sɔm vaysin, mɔ di layf vaysin, nɔ kin kɔmpit wit dis mɛrɛsin. So yu fɔ tɛl yu dɔktɔ bɔt dat bak.
• Yu gɛt bɛlɛ? Ɔ yu de tray fɔ gɛt bɛlɛ? Ɛni mɛrɛsin fɔ tek tɛm pasmak we yu gɛt bɛlɛ. Yu fɔ tɔk bɔt dis wit yu dɔktɔ. Dɛn go disayd if dis mɛrɛsin go afɛkt di pikin ɔ nɔ go afɛkt am.
• Yu na mama we de gi pikin in bɛlɛ? Tɛl yu dɔktɔ bɔt dis bak, bikɔs mɛrɛsin kin pas to yu pikin tru in mama in milk.
• Yu gɛt ɛni wikɛd tin ɔ prɔblɛm wit yu imyun sistɛm? Dis infɔmeshɔn impɔtant bak bikɔs dis mɛrɛsin gɛt fɔ du wit di imyun sistɛm.

Aw yu kin yuz dis mɛrɛsin?

Vedolizumab nɔto pil ɔ srɔp we yu kin bay na famasi ɛn tek na os. Dɛn kin gi am as infushɔn we dɛn kin put insay di bɛlɛ . Na yu wɛlbɔdi tim de gi am na ɔspitul ɔ spɛshal klinik. Dis min se dɔktɔ ɔ nɔs we dɛn tren fɔ du dis kayn tritmɛnt go gi yu di injɛkshɔn. Bɔku tɛm, i kin tek lɛk af awa so fɔ gi yu di injɛkshɔn. Dɛn go de wach yu fɔ sɔm tɛm we dɛn de gi yu di injɛkshɔn ɛn afta dɛn dɔn gi yu fɔ si if yu gɛt ɛni sayd ɛfɛkt.

Dɔn bak, we dɛn gi yu dis mɛrɛsin, di famasi go gi yu wan spɛshal instrɔkshɔn liflet (MedGuide) . I gɛt rili impɔtant tin dɛn bɔt dis mɛrɛsin, di sayd ɛfɛkt dɛn, ɛn tin dɛn we wi fɔ tek tɛm wit. Yu fɔ tek tɛm rid da liflet de ɛvri tɛm we yu gɛt nyu mɛrɛsin. Na bikɔs i gɛt bɔku tin dɛn we yu nid fɔ no bɔt. If ɛnitin de we yu nɔ ɔndastand, aks yu dɔktɔ ɔ nɔs.

Yu tink se dɛn kin gi pikin dɛn dis mɛrɛsin?Naw, dɛn nɔ gri fɔ yuz dis mɛrɛsin fɔ pikin dɛn. So, if yu pikin gɛt dis sik, i go fayn fɔ mek yu tɔk to dɔktɔ we de mɛn pikin dɛn bɔt am.

Wetin yu go du if yu aksidɛntli tek bɔku mɛrɛsin (ɔvados)? Di chans fɔ mek dis apin rili smɔl, bikɔs dɛn kin gi dis na ɔspitul, ɔnda dɔktɔ in sɔpɔtishɔn. Bɔt if yu tink se yu dɔn tek bɔku mɛrɛsin, kɔl pɔyzin kɔntrol sɛnta ɔ imejensi rum wantɛm wantɛm.

I rili impɔtant: Dis mɛrɛsin na fɔ yu nɔmɔ . Nɔr sheb dis mɛrɛsin wit ɔda pɔrsin, ivin if dɛn gɛt di sem sayn dɛm lɛk yu. Nɔto ɔlman fayn fɔ gɛt di sem mɛrɛsin, ɛn i nɔ fayn fɔ gi dis mɛrɛsin to ɛnibɔdi we nɔ gɛt dɔktɔ in advays.

Wetin yu kin du if yu mis apɔntinmɛnt fɔ tek mɛrɛsin?

Dɛn kin gi dis mɛrɛsin wan tɛm ɛvri sɔm wik. So, if yu nɔ ebul fɔ kam insay fɔ yu injɛkshɔn di de ɛn tɛm we dɛn dɔn sɛtul, dat na , if yu nɔ ebul fɔ kip yu apɔntinmɛnt, kɔl yu wɛlbɔdi tim wantɛm wantɛm ɛn mek dɛn no . I rili impɔtant fɔ tek dis mɛrɛsin jɔs lɛk aw dɛn dɔn plan fɔ tek am. Bikɔs na da tɛm de yu go gɛt mɔ bɛnifit frɔm di mɛrɛsin. Dɛn go tɛl yu wetin fɔ du nɛks, ɛn sɔntɛm dɛn go ebul fɔ chenj di tɛm fɔ am fɔ nyu de.

Us ɔda tin dɛn kin miks wit dis mɛrɛsin?

We yu de tek Vedolizumab, ɔda mɛrɛsin dɛn we yu de tek kin afɛkt yu tritmɛnt. So, i rili impɔtant fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek.

Vedolizumab kin intarakt wit dɛn mɛrɛsin ya mɔ:

• Stɛroyd mɛrɛsin dɛn: Fɔ ɛgzampul, mɛrɛsin dɛn lɛk prɛdnison ɔ kɔtizɔn . Dɛn kin gi dɛn tin ya bak sɔm tɛm fɔ inflamɛns na di bɔdi.
• TNF-alpha inhibitors: Dɛn wan ya na mɛrɛsin dɛn bak we gɛt fɔ du wit di imyun. Sɔm ɛgzampul dɛn na natalizumab , adalimumab , ɛn infliximab . If yu tek dɛn mɛrɛsin ya wit vedolizumab, dat kin mek yu gɛt mɔ sik.
• Vaysin: I nɔ fayn fɔ gɛt vaysin, mɔ di layf vaysin, we yu de tek dis mɛrɛsin.

Dis list nɔto ɔltin we de insay di list. So, tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu dɔktɔ dɔn gi yu, ɛn ɛni mɛrɛsin we yu nɔ de tek, ɔyl, ɛn it we yu de tek. Tɛl yu dɔktɔ bak if yu de smok, drink rɔm, ɔ yuz ɔda drɔgs. Dɛn tin ya kin miks wit yu mɛrɛsin ɔr kin mek yu sik wɔs.

Wetin yu fɔ tek tɛm wit we yu de tek dis mɛrɛsin?

Yu mɛdikal tim go de wach yu wɛlbɔdi gud gud wan we yu de tek Vedolizumab. I impɔtant fɔ mek dɛn de chɛk yu ɔltɛm . Yu fɔ no bak bɔt dɛn tin ya:

• If yu sik nɔr de bɛtɛ, ɔr if i tan lɛk se dɛn de wɔs, tɛl yu dɔktɔ wantɛm wantɛm .
• Bikɔs yu imyun sistɛm kin chenj we yu de tek dis mɛrɛsin, yu kin gɛt infɛkshɔn mɔ. So, i bɛtɛ fɔ lɛ yu nɔ de nia pipul dɛn we sik . Nɔ tɔch pipul dɛn we gɛt fiva ɔ kol, ɛn nɔ fɔ de nia ples dɛn we pipul dɛn kin bɔku.
• If yu gɛt fiva, kol, trot we de at, kɔf, ɔda sayn dɛn we de sho se yu gɛt kol, ɔ yu bɔdi de at , nɔ fɔ tek mɛrɛsin fɔ yusɛf. Nɔ jɔs tink se, "Na jɔs kol." Kɔl yu dɔktɔ wantɛm wantɛm ɛn gɛt advays.
• Wɔnin we rili impɔtant: Na smɔl tɛm nɔmɔ, pan sɔm sik pipul dɛn, dis mɛrɛsin kin mek dɛn gɛt siriɔs infɛkshɔn na dɛn bren we dɛn kɔl Progressive Multifocal Leukoencephalopathy (PML) . Dis kin mek pɔsin in layf de pan denja. So, if yu notis ɛni chenj na yu vishɔn (e.g., dabl vishɔn, blurred vision), chenj na yu tinkin (kɔnfyushɔn, mɛmori lɔs), trɔbul fɔ tɔk, trɔbul fɔ waka ɔ tinap, ɔ wik na wan say na yu bɔdi , tɛl yu wɛlbɔdi tim wantɛm wantɛm. If yu nɔ ebul fɔ kɔntakt dɛn, go to dɔktɔ kwik kwik wan. Pan ɔl we dis nɔ kin apin so ɔltɛm, i impɔtant fɔ no bɔt am.

Wetin na di sayd ɛfɛkt dɛm we dis mɛrɛsin kin gɛt?

Lɛk ɛni mɛrɛsin, Vedolizumab kin mek sɔm sayd ɛfɛkt. Bɔt, nɔto ɔlman kin gɛt dɛn. Sɔm pipul dɛn kin du wɛl wit di mɛrɛsin we nɔ gɛt ɛni sayd ɛfɛkt. Sɔm sayd ɛfɛkt dɛn kin siriɔs ɛn yu fɔ tɛl yu dɔktɔ wantɛm wantɛm. Sɔm nɔ kin siriɔs ɛn dɛn go go afta sɔm dez.

Sɔm bad tin dɛn we yu fɔ tɛl yu dɔktɔ bɔt wantɛm wantɛm:

If yu gɛt ɛni wan pan dɛn sik ya, tɛl yu wɛlbɔdi tim kwik kwik wan:

• Alɛji riakshɔn: skin de rɔsh, i de it bad bad wan, ayv (lɛk ɛkzema), yu fes, lip, tɔŋ, ɔ trot de swel - dis kin rili denja bikɔs i kin mek i nɔ izi fɔ blo.
• Diziz, nɔr de balans ɔr kɔdinɛt, kɔnfyushɔn ɔr trɔbul fɔ tɔk: Dɛn tin ya kin bi bak di sayn dɛm fɔ di bren infɛkshɔn we dɛn kɔl PML we wi bin dɔn tɔk bɔt.
• Sayn dɛn we de sho se pɔsin gɛt di sik:Fiva, kol, kɔf ɔ trot we de at ɔltɛm, bɔdi we de at, taya.
• Riakshɔn dɛn we yu kin gɛt we yu put yu bɔdi: Chɛst kin pen, yu nɔ kin blo fayn ɔ yu kin gɛt prɔblɛm fɔ blo, yu kin fil lɛk yu nɔ gɛt bɛtɛ trɛnk ɔ yu gɛt layt, yu skin kin rɛd, yu kin it. Dɛn tin ya kin apin jɔs afta di injɛkshɔn ɔ jɔs afta dat.
• Sayn dɛm fɔ injuri na di liva: rayt ɔpa bɛlɛ de pen, yu nɔ de want fɔ it, yu de nɔs ɔ yu de vɔmit, yu stɔl we gɛt layt kɔlɔ, yu urine we gɛt dak yɔlɔ ɔ brawn urine, janda (yu skin ɔ yu yay de yɔlɔ), yu wik ɔ taya we nɔ kɔmɔn.

Di sayd ɛfɛkt dɛm we dɔktɔ nɔ kin nid fɔ tɔk bɔt, bɔt i fɔ tɔk bɔt if dɛn kɔntinyu fɔ de:

Bɔku tɛm, dɛn sayd ɛfɛkt ya nɔ kin siriɔs. Bɔku tɛm, dɛn kin go insay sɔm dez. Bɔt if dɛn kɔntinyu fɔ de ɔ de mɔna yu bɔku, tɛl yu dɔktɔ .

• Ed de at
• Taya
• Pen na di jɔyn dɛn
• Vɔmit
• Kɔmɔn kol simptom dɛm - trot we de at, nos we de rɔn
• Kɔf
• Rash na di skin

Dis list nɔ de inklud ɔl di sayd ɛfɛkt dɛn we pɔsin kin gɛt. If yu notis ɛnitin we nɔ kɔmɔn we nɔ de na dis list, aks yu dɔktɔ bɔt am. Yu kin ripɔt di sayd ɛfɛkt to di FDA (Food and Drug Administration) na 1-800-FDA-1088 na Amɛrika, ɔ to di rilevɛns wɛlbɔdi ɔtoriti dɛn tru yu dɔktɔ na Sri Lanka.

Usay yu kin kip di mɛrɛsin?

Dis nɔ go bi prɔblɛm fɔ yu. Bikɔs Vedolizumab nɔto mɛrɛsin we yu kin kɛr go na os. Na mɛrɛsin we dɛn kin gi na ɔspitul ɔ klinik nɔmɔ, ɛn dɛn kin kip am de ɔnda di rayt we fɔ kɔntrol di tɛmpracha . So yu nɔ nid fɔ wɔri bɔt aw fɔ kip di mɛrɛsin.

Di tin we impɔtant pas ɔl - di mɛsej we dɛn kin kɛr go na os

Okay, so wi don tok plenti boht Vedolizumab. I kin tan lɛk se na kɔmplikɛt mɛrɛsin, bɔt if yu ɔndastand am fayn ɛn fala yu dɔktɔ in instrɔkshɔn, i kin ɛp yu fɔ gɛt gud rilif frɔm yu inflammatory bowel disease (IBD).

Fɔ tɔk smɔl, Vedolizumab na spɛshal mɛrɛsin we dɛn kin gi insay di bɛlɛ fɔ inflammatory bowel diseases. E kin ɛp fɔ kɔntrol yu sayn dɛm, mek yu layf izi smɔl, ɛn ridyus di prɔblɛm dɛm wae de sik kin kam wit.

Mɛmba se, i impɔtant fɔ tɔk to yu dɔktɔ opin ɛn ɔnɛs bifo yu tritmɛnt ɛn di tɛm we yu de trit yu. If yu gɛt ɛni kwɛstyɔn ɔ tin we de mɔna yu, nɔ fred fɔ aks. Nɔ tink bɔt tin dɛn lɛk, "Dis na sɔntin we a fɔ aks?" "Wetin di dɔktɔ go tink?" Dɛn de de fɔ ɛp yu. Wi ɔl fɔ tray fɔ mek dɛn no bɔt wi, fɔ gɛt di rayt tritmɛnt, ɛn fɔ gɛt wɛlbɔdi.

A op se yu go si se dis infɔmeshɔn go ɛp yu! Wi de wish yu fɔ wɛl kwik kwik wan!

` Vedolizumab, inflammatory bowel disease, Crohn’s disease, ɔlsa kɔlayt, bɔdi sik, mɛrɛsin, sayd ɛfɛkt